Carlo Visco
University of Verona(IT)Inova Fairfax Hospital(US)Christian-Albrechts-Universität zu Kiel(DE)Azienda Ospedaliera Universitaria Integrata Verona(IT)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, Viral-associated cancers and disorders, CAR-T cell therapy research, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → Immunohistochemical Double-Hit Score Is a Strong Predictor of Outcome in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone(2012)679 cited
- → MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program(2013)672 cited
- → Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study(2020)551 cited
- → Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study(2012)383 cited
- → The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation(2011)376 cited